Fluoxetine for Visual Recovery After Ischemic Stroke
Status:
Terminated
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether fluoxetine, a selective serotonin reuptake
inhibitor commonly used for depression, enhances visual recovery after an acute ischemic
stroke.